other material
confidence high
sentiment neutral
materiality 0.50
Shuttle Pharma issues 3.74M common shares on preferred conversions; adds warrants for ~17.9M shares
Shuttle Pharmaceuticals Holdings, Inc.
- As of Sept 14, 2026, issued 2,869,595 common shares on Series B-1 preferred conversion and 867,887 on Series B-2 conversion.
- Issued warrants to purchase ~927,114 shares at $10.30 per share, exercisable for 3 years.
- Issued pre-funded warrants to purchase ~16,932,508 shares of common stock.
- All securities sold unregistered under Section 4(a)(2) exemption, following stockholder approval at Sept 9 special meeting.